CSF biomarker pathology correlates with a medial temporo-parietal network affected by very mild to moderate Alzheimer's disease but not a fronto-striatal network affected by healthy aging.
about
The Alzheimer's disease neuroimaging initiative: progress report and future plansCognitive decline and brain pathology in aging--need for a dimensional, lifespan and systems vulnerability view.New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us?The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognitionBrain-derived neurotrophic factor is associated with age-related decline in hippocampal volume.Fractional anisotropy shows differential reduction in frontal-subcortical fiber bundles-A longitudinal MRI study of 76 middle-aged and older adults.Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity.Faster cognitive decline in the years prior to MR imaging is associated with smaller hippocampal volumes in cognitively healthy older personsAlzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individualsGray-matter macrostructure in cognitively healthy older persons: associations with age and cognition.Neuroimaging results impose new views on Alzheimer's disease--the role of amyloid revised.Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD.Pre-dementia memory impairment is associated with white matter tract affection.Healthy Aging and Dementia: Two Roads Diverging in Midlife?
P2860
Q28749585-2B61C3C7-6EFB-4553-913D-3F3CB5E3DFFDQ30800136-3B90AAF6-F1A1-4BD0-A20E-F849357D8465Q33881726-E470D350-DF20-4A26-9C1F-F2E017F94600Q33902744-53043779-AA34-4BF9-83CE-07D387D4B3F2Q34110183-D3C50A82-E0A3-43E1-B082-CF734E494200Q35609077-610E6EBF-F79A-4DF7-84C8-32A677428396Q35895780-EEAD3D7A-CFB9-457D-91CE-B1559628FB38Q36902996-A5907008-0FD5-4D1A-AF46-10F602FBF470Q36943464-E1330304-0678-4F92-BE3A-F43497AA6C44Q37589292-4427219D-19F8-4C59-A472-C5457B0B006EQ37971458-E10F9C6F-CA4D-40DE-ACA2-1E92A5E578E9Q38493709-DBB1D02B-95BD-4892-AE43-5572990AB7BEQ51030026-A8B02C6C-B6BD-4A88-9332-97B9ACAA3BC1Q57072466-74FD4C43-8424-4519-9539-47F51ECBF6FB
P2860
CSF biomarker pathology correlates with a medial temporo-parietal network affected by very mild to moderate Alzheimer's disease but not a fronto-striatal network affected by healthy aging.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
CSF biomarker pathology correl ...... ork affected by healthy aging.
@en
CSF biomarker pathology correl ...... ork affected by healthy aging.
@nl
type
label
CSF biomarker pathology correl ...... ork affected by healthy aging.
@en
CSF biomarker pathology correl ...... ork affected by healthy aging.
@nl
prefLabel
CSF biomarker pathology correl ...... ork affected by healthy aging.
@en
CSF biomarker pathology correl ...... ork affected by healthy aging.
@nl
P2093
P50
P921
P1433
P1476
CSF biomarker pathology correl ...... ork affected by healthy aging.
@en
P2093
Anders Skinningsrud
Atle Bjørnerud
Dag E Eilsertsen
Tormod Fladby
Vidar Stenset
P304
P356
10.1016/J.NEUROIMAGE.2009.09.029
P407
P577
2009-09-30T00:00:00Z